| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.27B | $693.4M | $531.8M |
| YoY Revenue Growth % | +83.4% | +30.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$252.9M | -$691.1M | -$196.1M |
| Operating Margin % | -19.9% | -99.7% | -36.9% |
| Net Income (GAAP) | -$245.0M | -$705.8M | -$214.1M |
| EBITDA (Normalized) | -$236.0M | -$673.4M | -$176.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$218.1M | -$189.0M | -$214.3M |
| Capital Expenditures (CapEx) | $21.0M | $22.1M | $23.9M |
| Free Cash Flow (FCF) | -$239.1M | -$211.2M | -$238.3M |
| FCF Margin % | -18.8% | -30.5% | -44.8% |
| Return on Invested Capital (ROIC %) | -29.0% | -45.0% | -3.3% |
| Cash & Short-Term Equivalents | $604.8M | $341.0M | — |
| Total Debt (Short + Long Term) | $802.6M | $391.4M | $1.82B |
| Total Stockholders' Equity | $491.3M | $56.3M | $3.73B |